www.ijcspub.org © 2023 IJCSPUB | Volume 13, Issue 2 May 2023 | ISSN: 2250-1770 IJCSP23B1327 International Journal of Current Science (IJCSPUB) www.ijcspub.org 750 A REVIEW ON SEPSIVAC INJECTION (MYCOBACTERIUM W) AN EMERGENCY MEDICATION 1 Vishal bodke, 2 Ruchita Badekar, 3 Pavankumar Dhoble, 4 Prajval Birajdar, 5 Swapnil D Phalak, 1. Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar college of pharmacy and Research institute, Karjat, Maharashtra, India 2.Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar college of pharmacy and Research institute, Karjat, Maharashtra, India 3. Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar college of pharmacy and Research institute, Karjat, Maharashtra, India 4.Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar college of pharmacy and Research institute, Karjat, Maharashtra, India 5.Assistant Professor Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar college of pharmacy and Research institute, Karjat, Maharashtra, India Abstract:- The mycobacterium w (Mw) has improved outcomes for individuals with severe sepsis by acting as an immunomodulator. Mw is typically administered intradermally (ID), with a maximum injection volume of 0.1 millilitres (mL). The intradermal approach can be substituted with the intravenous (IV) route. Sepsis is a potentially fatal infection that is treated with sepsivac.It employs a two-pronged strategy that increases innate immunity and reduces the body's inflammatory response. Immunity is both inherent and learned in humans. A person's natural immunity is activated by sepsivac. Traditional vaccinations or acquired immunity function through antibodies. Comparing Sepsivac to a typical vaccination is not appropriate. It prevents inflammatory cytokines like IL6 from attacking the organs. Body's intrinsic immunity will kick in if organ damage is contained. Sepsivac, an immunomodulator used to treat leprosy, has been given the go-ahead to be used in the Philippines to treat Covid-19. According to a corporate representative, the Food and Drug Administration of the Philippines approved on September 15. Keywords:- Mycobacterium w, Corona, Immunity, cells, Injections etc.